Exane Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Exane Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-38,505	Closed	-$1.1M	–	117
2018 Q4	$1.1M	Sell	38,505 -178	-0.5%	-$5.06K	0.65%	29
2018 Q3	$1.08M	Sell	38,683 -12,915	-25%	-$363K	0.34%	45
2018 Q2	$1.44M	Sell	51,598 -60,000	-54%	-$1.61M	0.62%	29
2018 Q1	$2.77M	Hold	111,598	–	–	0.83%	25
2017 Q4	$2.7M	Buy	111,598 +51,598	+86%	+$1.36M	0.84%	23
2017 Q3	$1.66M	Buy	+60,000	New	+$1.6M	0.32%	38

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Exane Asset Management's NXTM Position: Q1 2019 in Review

Exane Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 38,505 shares — an estimated $1.1M sold.

Exane Asset Management first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $2.77M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Exane Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Exane Asset Management sold 38,505 NxStage Medical Inc. shares in Q1 2019, an estimated $1.1M.
Exane Asset Management first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Exane Asset Management's NxStage Medical Inc. position peaked at $2.77M in Q1 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Exane Asset Management's 13F filing for Q1 2019, filed 7 May 2019.